120 related articles for article (PubMed ID: 26201318)
1. Alcohol, TLR4-TGF-β antagonism, and liver cancer.
Tsukamoto H; Mishra L; Machida K
Hepatol Int; 2014 Sep; 8 Suppl 2(Suppl 2):408-12. PubMed ID: 26201318
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
[TBL] [Abstract][Full Text] [Related]
3. TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis.
Machida K; Feldman DE; Tsukamoto H
Adv Exp Med Biol; 2015; 815():131-44. PubMed ID: 25427905
[TBL] [Abstract][Full Text] [Related]
4. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus.
Machida K; Chen CL; Liu JC; Kashiwabara C; Feldman D; French SW; Sher L; Hyeongnam JJ; Tsukamoto H
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):19-22. PubMed ID: 22320911
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.
Chen CL; Tsukamoto H; Machida K
Hepatol Int; 2014 Jul; 8(3):330-8. PubMed ID: 26202636
[TBL] [Abstract][Full Text] [Related]
7. NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells.
Machida K
Adv Exp Med Biol; 2018; 1032():105-113. PubMed ID: 30362094
[TBL] [Abstract][Full Text] [Related]
8. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
[TBL] [Abstract][Full Text] [Related]
9. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog.
Machida K; Tsukamoto H; Mkrtchyan H; Duan L; Dynnyk A; Liu HM; Asahina K; Govindarajan S; Ray R; Ou JH; Seki E; Deshaies R; Miyake K; Lai MM
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1548-53. PubMed ID: 19171902
[TBL] [Abstract][Full Text] [Related]
11. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
12. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.
Machida K
Drug Deliv Transl Res; 2013 Apr; 3(2):152-64. PubMed ID: 25787983
[TBL] [Abstract][Full Text] [Related]
13. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
14. p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs.
Choi HY; Siddique HR; Zheng M; Kou Y; Yeh DW; Machida T; Chen CL; Uthaya Kumar DB; Punj V; Winer P; Pita A; Sher L; Tahara SM; Ray RB; Liang C; Chen L; Tsukamoto H; Machida K
Nat Commun; 2020 Jun; 11(1):3084. PubMed ID: 32555153
[TBL] [Abstract][Full Text] [Related]
15. HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment.
Benzoubir N; Lejamtel C; Battaglia S; Testoni B; Benassi B; Gondeau C; Perrin-Cocon L; Desterke C; Thiers V; Samuel D; Levrero M; Bréchot C; Bourgeade MF
J Hepatol; 2013 Dec; 59(6):1160-8. PubMed ID: 23928402
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
[TBL] [Abstract][Full Text] [Related]
17. LIN28 and histone H3K4 methylase induce TLR4 to generate tumor-initiating stem-like cells.
Hernandez JC; Chen CL; Machida T; Uthaya Kumar DB; Tahara SM; Montana J; Sher L; Liang J; Jung JU; Tsukamoto H; Machida K
iScience; 2023 Mar; 26(3):106254. PubMed ID: 36949755
[TBL] [Abstract][Full Text] [Related]
18. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol.
Machida K
Chem Biol Interact; 2020 May; 323():109055. PubMed ID: 32171851
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
20. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
